Alendronate Sodium Tablets

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

DLA TROOP SUPPORT

Contract Value

Not provided

Codes & Classification
Solicitation Number

SPE2D2-25-R-0023

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

6505

Additional Details
Set Aside

None

Place of Performance

-

SourceSAM
Documents2
The Defense Logistics Agency (DLA) Troop Support has issued a solicitation (Procurement Identifier: SPE2D2-25-R-0023) for the supply of Alendronate Sodium Tablets, classified under NAICS Code 325412 (Pharmaceutical Preparation Manufacturing, 2022 version) and Product Service Code 6505. This procurement is intended to support federal requirements for pharmaceutical products, specifically targeting the provision of Alendronate Sodium Tablets, which are commonly used in the treatment of osteoporosis and related bone conditions. The scope of this solicitation encompasses the manufacturing and delivery of Alendronate Sodium Tablets in accordance with all applicable federal standards and specifications. Contractors are expected to ensure consistent quality, regulatory compliance, and reliable supply throughout the contract lifecycle. The intended outcome is to secure a dependable source of this essential medication for use by federal entities, supporting the health and readiness of personnel. Key requirements include adherence to pharmaceutical manufacturing standards as defined by the NAICS classification, with all deliverables meeting the necessary regulatory and quality benchmarks. The solicitation remains unchanged except for Amendment 0001, which extends the closing date for responses to November 3, 2025, providing additional time for interested parties to submit their proposals. All other terms and conditions of the original solicitation remain in effect. The contracting entity for this opportunity is DLA Troop Support, a federal office responsible for the procurement and distribution of medical and pharmaceutical supplies. Interested contractors should direct inquiries to the primary contact, Courtney Hunter ([email protected]), or the secondary contact, Jason Wray ([email protected], phone: 445-737-6304). The solicitation is currently active and can be accessed via the official SAM.gov portal at https://sam.gov/opp/a4d10e358227408e852b180eb152d56c/view, where additional attachments related to the opportunity are available for review. This is a federal solicitation, and contractors should review all posted documentation for specific requirements, terms, and conditions. No set-aside requirements or special considerations have been indicated in the provided information. The opportunity is suitable for organizations with established capabilities in pharmaceutical preparation manufacturing, particularly those experienced in producing oral tablet formulations for government clients. Contractors evaluating this opportunity should ensure their ability to meet the technical, regulatory, and logistical demands of supplying Alendronate Sodium Tablets over the duration of the contract, as well as their capacity to comply with all federal procurement protocols as outlined by DLA Troop Support.